Records 1 - 10
| Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma.
Thoracic cancer 2021 Oct .
Zhang Huan, Shan Guangyao, Cai Benjie, Bi Guoshu, Chen Zhencong, Liang Jiaqi, Besskaya Valeria, Zheng Yuansheng, Guo Weigang, Wang Lin, Xu Songtao, Zhan Che
| Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418).
Thoracic cancer 2020 Dec .
Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, de Lima Vladmir Cordei
| Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution.
Thoracic cancer 2020 Jul .
Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi
| Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status.
Thoracic cancer 2020 Feb .
Arrieta Oscar, Ramírez-Tirado Laura-Alejandra, Caballé-Perez Enrique, Mejia-Perez Alberto, Zatarain-Barrón Zyanya Lucia, Cardona Andrés F, Lozano-Ruíz Francisco, Segura-González Manuel, Cruz-Rico Graciela, Maldonado Federico, Rosell Rafa
| The prognostic implications of EGFR mutation and ALK rearrangement for the long-term outcomes of patients with resected lung adenocarcinomas.
Thoracic cancer 2019 Jun .
Kim Hyungjin, Lee Hyun-Ju, Hong Hyunsook, Kim Young Jae, Kim Kwang Gi, Jeon Yoon Kyung, Kim Young T
| Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer.
Thoracic cancer 2019 (4): 695-707.
Chen Ying, Li Guangjian, Lei Yujie, Yang Kaiyun, Niu Huatao, Zhao Jie, He Rui, Ning Huanqi, Huang Qiubo, Zhou Qinghua, Huang Yunch
| PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1.
Thoracic cancer 2019 01 10 (1): 103-110.
Lee Jongmin, Park Chan Kwon, Yoon Hyoung-Kyu, Sa Young Jo, Woo In Sook, Kim Hyo Rim, Kim Sue Youn, Kim Tae-Ju
| Clonally-related primary ALK rearranged adenocarcinoma and associated metastatic lesions.
Thoracic cancer 2018 May .
Zhu You-Cai, Deng Yun-Te, Wang Wen-Xian, Xu Chun-Wei, Zhuang Wu, Du Kai-
| Clinicopathological features of younger (aged = 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene.
Thoracic cancer 2018 Mar .
Kometani Takuro, Sugio Kenji, Osoegawa Atsushi, Seto Takashi, Ichinose Yuki
| Expression and copy number gains of the RET gene in 631 early and mid stage non-small cell lung cancer cases.
Thoracic cancer 2018 Feb .
Tan Ling, Hu Yerong, Tao Yongguang, Wang Bin, Xiao Jun, Tang Zhenjie, Lu Ting, Tang H